Connect for Well-being & Longevity

Iga City, Mie Prefecture x Rohto Pharmaceutical Co., Ltd. conduct a pilot educational program to prevent myopia in children.

Focusing on CMC damage inside the hair caused by sunlight, potassium hyaluronate was confirmed to have an effect in suppressing "frizz recurrence."

Rohto has discovered that its unique milk peptide ingredient acts not only on bones and blood, but also on growing muscles!

Rohto Pharmaceutical's "Mirumirunobiru" project has launched.

Rohto Pharmaceutical joins "ASAGI Labs Longevity Consortium"

Regarding the issue of the old DRX brand website URL being redirected to a fraudulent site.

Initiatives to Ensure Safety in Cell Therapy

Notice of changes to packaging specifications due to environmental considerations

Publication of "Rohto Health White Paper 2025"

Please purchase from authorized Obagi retailers.

The recipients of the 17th Rohto Women's Health Science Research Award have been decided.

The winners of the 31st ROHTO AWARD research grants have been decided.

Recipients of the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)" have been decided

We are pleased to announce the 19th recipient of Rohto Prize, a research fund specializing in Japanese Association of Geriatric Dermatology Research Fund skin.

Announcement of the public call for applications for the "Japanese Dermatological Association Dermatological Research Fund (Endowment by Rohto Pharmaceutical)"